Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

Market Cap	6.61B +16.2%
Revenue (ttm)	699.33M +33.8%
Net Income	-27.51M
EPS	-0.07
Shares Out	420.78M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,118,078
Open	16.01
Previous Close	15.72
Day's Range	15.62 - 18.58
52-Week Range	11.40 - 22.55
Beta	0.52
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:688488

Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. It offers anti-HIV drugs and human-derived proteins. The company also provides anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 735
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688488

Financial Performance

In 2025, SHA:688488's revenue was 719.17 million, an increase of 72.13% compared to the previous year's 417.80 million. Losses were -19.53 million, -86.17% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 15, 2026

Data Sources Report a data error